Key Metrics
CiteScore 

2.7
H-Index 

19
SJR 

Q2Pharmacology (medical)

SNIP 

0.87
Recommended pre-submission checks
Powered by 

Topics Covered on Drugs - Real World Outcomes
Drugs - Real World Outcomes Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2190 | USD 2690 | GBP 1890 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Drugs - Real World Outcomes ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drugs - Real World Outcomes
Opioid Therapy Discontinuation in General Practice: Associations with Adjunct Therapies and Somatoform Pain Disorders.
- 3 Aug 2026
- Drugs - real world outcomes
Real-World Effectiveness and Safety of Dotinurad in Chinese Patients with Gout: A Comparative Analysis.
- 31 Jul 2026
- Drugs - real world outcomes
Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa: An Observational Cohort Study Based on Insurance Claims in the USA.
- 29 Jul 2026
- Drugs - real world outcomes
Feasibility of Reconstructing Survival Outcomes from Unstructured Electronic Medical Records under Japan's Next-Generation Medical Infrastructure Act: A Historical Cohort Study of Atezolizumab in Non-small Cell Lung Cancer.
- 23 Jul 2026
- Drugs - real world outcomes
Calcitonin Gene-Related Peptide Monoclonal Antibody Utilization and Treatment Gaps in People with Migraine in Japan: Results from the OVERCOME (Japan) 2nd Study.
- 23 Jul 2026
- Drugs - real world outcomes
Treatment Selection Patterns and Associated Outcomes for Biguanides and SGLT2 Inhibitors in Type 2 Diabetes: A Retrospective Database Study in Japan.
- 13 Jul 2026
- Drugs - real world outcomes
Opioid Therapy Discontinuation in General Practice: Associations with Adjunct Therapies and Somatoform Pain Disorders.
- 3 Aug 2026
- Drugs - real world outcomes
Real-World Effectiveness and Safety of Dotinurad in Chinese Patients with Gout: A Comparative Analysis.
- 31 Jul 2026
- Drugs - real world outcomes
Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa: An Observational Cohort Study Based on Insurance Claims in the USA.
- 29 Jul 2026
- Drugs - real world outcomes
Feasibility of Reconstructing Survival Outcomes from Unstructured Electronic Medical Records under Japan's Next-Generation Medical Infrastructure Act: A Historical Cohort Study of Atezolizumab in Non-small Cell Lung Cancer.
- 23 Jul 2026
- Drugs - real world outcomes
Calcitonin Gene-Related Peptide Monoclonal Antibody Utilization and Treatment Gaps in People with Migraine in Japan: Results from the OVERCOME (Japan) 2nd Study.
- 23 Jul 2026
- Drugs - real world outcomes
Treatment Selection Patterns and Associated Outcomes for Biguanides and SGLT2 Inhibitors in Type 2 Diabetes: A Retrospective Database Study in Japan.
- 13 Jul 2026
- Drugs - real world outcomes